J. Goldberg
Molecular Biology · 2012–2022
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 35 citations into it
- Ecology — 10 citations into it
Whom J. Goldberg trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Goldberg's perspective
Ordered by how strongly the researchers J. Goldberg trusts endorse each paper. Same corpus, a different order for every researcher.
- Short pyrosequencing reads suffice for accurate microbial community analysis (Nucleic Acids Research)
- Diversity of the Human Intestinal Microbial Flora (Science)
- A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies (PLoS ONE)
- QIIME allows analysis of high-throughput community sequencing data (Nature Methods)
- Metagenomic biomarker discovery and explanation (Genome Biology)
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy (Applied and Environmental Microbiology)
- Greengenes: Chimera-checked 16S rRNA gene database and workbench compatible in ARB
- The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing (PLoS Biology)
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation (Proceedings of the National Academy of Sciences of the United States of America)
- A core gut microbiome in obese and lean twins (Nature)
Their papers
- Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. (2012) — 929 citations
- Teclistamab in Relapsed or Refractory Multiple Myeloma (2022) — 843 citations
- Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. (2021) — 1,261 citations
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (2017) — 1,779 citations
- Intestinal Blautia is associated with reduced death from graft-versus-host disease (2015) — 657 citations